Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To demonstrate the relative bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride capsules under fed and fasted conditions.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fasting Conditions. |
|
| 2 | Experimental | Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions. |
|
| 3 | Active Comparator | Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fasting Conditions | Drug |
| ||
| Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions |
| Measure | Description | Time Frame |
|---|---|---|
| Bioequivalence based on AUC and Cmax | 53 days |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Richard Lalonde, Pharm.D. | Phoenix International Life Science Inc. | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
|
| Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions | Drug |
|
| ID | Term |
|---|---|
| D003863 | Depression |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D002997 | Clomipramine |
| ID | Term |
|---|---|
| D003984 | Dibenzazepines |
| D006575 | Heterocyclic Compounds, 3-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided